|
Apr 9
|
Corcept (CORT) Completes Enrollment in Ovarian Cancer Study
|
|
Apr 9
|
Palatin (PTN) Up 15% on Results From Dry Eye Disease Study
|
|
Apr 9
|
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
|
|
Apr 8
|
Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why
|
|
Apr 8
|
MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why
|
|
Apr 5
|
Wall Street Analysts Think ANI (ANIP) Is a Good Investment: Is It?
|
|
Apr 4
|
Gritstone (GRTS) Plummets 58% in a Week: Here's Why
|
|
Apr 4
|
Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe
|
|
Apr 4
|
ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis
|
|
Apr 3
|
EMA Accepts Rocket (RCKT) Gene Therapy Filing for Fanconi Anemia
|
|
Apr 3
|
ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium
|
|
Apr 2
|
ANI Pharmaceuticals (ANIP) Dips More Than Broader Market: What You Should Know
|
|
Apr 2
|
Avalo Therapeutics (AVTX) Surges 270% in a Week: Here's Why
|
|
Apr 2
|
Vertex (VRTX) Moves Kidney Disease Drug to Phase 3 Development
|
|
Apr 2
|
Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study
|
|
Mar 28
|
Moderna (MRNA) Posts Pipeline Progress, Secures Blackstone Funding
|
|
Mar 27
|
ANI Pharmaceuticals (ANIP) Rises Yet Lags Behind Market: Some Facts Worth Knowing
|
|
Mar 27
|
Praxis (PRAX) Surges on Positive Epilepsy Study Results
|
|
Mar 27
|
ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USP
|
|
Mar 26
|
Axsome's (AXSM) Narcolepsy Drug Study Meets Primary Goal
|